Degenerative Disc Disease News and Research

RSS

DePuy Synthes introduces new CONCORDE LIFT Implant to treat patients with degenerative disc disease

Johnson & Johnson Medical Devices Companies today announced that DePuy Synthes is launching the CONCORDE LIFT Expandable Interbody Device in the U.S.

From DePuy Synthes 27 Jul 2018

Jury’s in: Opioids are not better than other medicines for chronic pain

A few years ago, Renea Molden’s doctors told her they wanted to take her off her opioid pills. It did not sound like good idea to her.

6 Mar 2018

DePuy Synthes launches CONCORDE Clear MIS Discectomy Device to simplify spinal fusion surgery

DePuy Synthes today announced the launch of CONCORDE Clear MIS Discectomy Device, a surgical solution designed to simplify discectomy in minimally invasive spinal fusion surgery.

From DePuy Synthes 12 Dec 2017

K2M announces U.S. launch of innovative 3D-printed CASCADIA product portfolio at 2016 NASS meeting

K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine and minimally invasive spine technologies and techniques, today announced the U.S. launch of its award-winning CASCADIA Interbody Systems, featuring Lamellar 3D Titanium Technology, during the 31st North American Spine Society (NASS) Annual Meeting, Oct. 26-29, 2016, in Boston at Booth #1615.

27 Oct 2016

Neck pain more common in women than in men, Loyola study finds

Women are 1.38 times more likely than men to report neck pain due to cervical degenerative disc disease, according to a study of adult patients treated at Loyola Medicine's Pain Management Center.

9 Mar 2016

Smoking linked to worsening degenerative disc disease in cervical spine

Adding to the already length list of reasons not to smoke, researchers have connected smoking to worsening degenerative disc disease in the cervical spine, according to research presented this week at the Association of Academic Physiatrists Annual Meeting in Sacramento, Calif.

18 Feb 2016

New, personalized approach to detecting low back pain

Scientists at The Feinstein Institute for Medical Research have discovered a new, personalized approach to diagnosing low back pain. The findings from a clinical study show that serum levels of the proinflammatory cytokine interleukin-6 (IL-6) vary in individuals with lumbar intervertebral disc disease and that biochemical profiling of circulating cytokines may assist in refining personalized diagnoses of disc diseases.

8 Jan 2016

Combining NELL-1 with BMP2 therapy may promote bone development

Bone morphogenetic protein-2 (BMP2) is used clinically to promote bone repair. However, the high BMP2 concentrations required to stimulate bone growth in humans may produce life-threatening adverse effects such as cervical swelling in spinal fusion procedures, a problem that prompted an FDA warning in 2008.

7 Jan 2016

Samumed to present preclinical and clinical data on Wnt pathway for OA treatment at ACR 2015

Samumed, LLC, a leader in tissue regeneration, announced today that it will present preclinical and clinical data on a small molecule modulator of the Wnt pathway (SM04690, an investigational new drug) for potential disease modifying treatment of osteoarthritis (OA) of the knee at 2015 American College of Rheumatology Annual Meeting.

4 Nov 2015

FDA grants first cervical multilevel indication to Centinel Spine’s STALIF C integrated interbody device

Centinel Spine, Inc., the pioneer of Stand-Alone, No-Profile, Integrated Interbody fusion devices was granted the first cervical multilevel indication for a Stand-Alone interbody device by the U.S. Food and Drug Administration (FDA).

30 Jun 2015

Amedica receive FDA clearance for multi-level cervical interbody cage indications

Amedica Corporation, a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, announced today that the U.S. Food and Drug Administration has expanded the indications of Amedica’s silicon nitride interbody fusion products to include multi-level cervical treatment.

4 Feb 2015

Benvenue Medical's Luna 360 System receives FDA clearance for spinal fusion treatment of DDD

Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, today announced that the company's Luna 360 Interbody Fusion System has received 510(k) clearance from the U.S. Food and Drug Administration for spinal fusion treatment of symptomatic degenerative disc disease (DDD).

2 Dec 2014

Interventional Spine's Lateral Opticage Expandable Intervertebral Body Fusion Device gets FDA approval

Interventional Spine, Inc. today announced FDA clearance of its Lateral Opticage Expandable Intervertebral Body Fusion Device. This device joins the Interventional Spine family of Opticage Expandable Interbody Fusion Devices previously cleared for TLIF earlier this year, and used with the Company's PerX360 System.

25 Nov 2014

Research report on the U.S. spinal implant market

Decision Resources Group finds that the United States spinal implant market will expand modestly through 2022 to reach a value of nearly $7.1 billion.

7 Aug 2014

Nanogel heals burn wounds faster

Researchers at the Institute of Bioengineering and Nanotechnology have developed a nanogel that can accelerate the healing of burn wounds to minimize the risk of infection and scarring. The technology is based on IBN’s proprietary self-assembling ultrashort peptide technology, which are short sequences of amino acids.

16 May 2014

Study: Stem cell transplant effective in halting degenerative disc disease of spine

Stem cell transplant was viable and effective in halting or reversing degenerative disc disease of the spine, a meta-analysis of animal studies showed, in a development expected to open up research in humans.

10 Mar 2014

Minimally invasive surgery outcomes show favorable results in low back pain patients

Beaumont research findings published in the February online issue of Spine shows that patients who have a low back surgery called minimally invasive transforaminal lumbar interbody fusion, end up better off in many ways than patients who have more invasive surgery to alleviate debilitating pain.

5 Mar 2014

Gulf Coast Spine Care now offers new, improved treatment for degenerative disc disease

Degenerative disc disease affects many individuals, and it can cause a significant amount of pain to those affected. Its most common cause is related to aging and deterioration of the bones in the spine, and pain from the condition results when two or more vertebrae move and place pressure on the spine. This is a condition that often is associated with both a herniated disc and spinal stenosis.

23 Jan 2014

DePuy Synthes develops CONFORM SHEET allograft implant for spinal fusion surgery

DePuy Synthes Spine, in collaboration with DePuy Synthes Biomaterials, announced today the U.S. launch of CONFORM SHEET™, a hydrated, pliable and totally demineralized cancellous bone matrix that fills voids during posterolateral spinal fusion surgery and provides a natural scaffold for new bone formation.

7 Jan 2014

CUMC researchers make new breakthrough in regenerative medicine

As fast-growing biotech company Rainbow Coral Corp. works to deliver new cutting-edge treatments in the field of regenerative medicine, a major new breakthrough could soon lead to growing new lungs for patients in a laboratory.

3 Dec 2013